Data Availability
The data supporting the findings of this study are accessible from the Korea National Health Insurance Service, but availability is restricted as these data were utilized under license for the current study and are not publicly accessible. However, the data can be obtained from the Korea National Health Insurance Service upon reasonable request and following the appropriate review process.
Posted December 21, 2023.
The effect of SGLT2 inhibitor on clinical outcomes in patients with type 2 diabetes and atrial fibrillation
